All News

2061 articles, sorted by publication time.

Cancer Research · us

Making Prostate Cancer Sensitive to Drugs Again: Study Finds Clues to How Transfer RNA Regulates Cell Identity

Cancer cells changing identity and escaping their dependence on androgen signaling is one reason advanced prostate cancer is difficult to treat. A new study found that restoring a specific transfer RNA can restore treatment sensitivity in experimental cells; how to turn this pathway into a safe and effective therapy remains unanswered.

Clinical Trials · global

Iberdomide Triplet Therapy Delays Myeloma Progression: Median Progression-Free Survival Reaches 42 Months in Phase 3 Trial

A confirmatory analysis of 800 patients showed that the iberdomide combination reduced the risk of disease progression or death by 51% compared with the control group, adding evidence of clinical benefit to the accelerated approval previously supported by minimal residual disease measures; overall survival and full safety results have yet to be disclosed.